| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
23,462 |
20,705 |
$3.39M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,888 |
17,171 |
$3.18M |
| 71045 |
Radiologic examination, chest; single view |
10,838 |
8,746 |
$1.28M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,448 |
6,642 |
$996K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,351 |
4,790 |
$773K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,310 |
9,628 |
$761K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,778 |
5,837 |
$465K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,381 |
6,313 |
$322K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,970 |
3,389 |
$299K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
799 |
661 |
$285K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,752 |
7,867 |
$274K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,171 |
4,899 |
$208K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,527 |
3,774 |
$176K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,473 |
1,161 |
$119K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,672 |
1,501 |
$117K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,150 |
1,069 |
$110K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,307 |
17,209 |
$104K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
330 |
126 |
$100K |
| 80053 |
Comprehensive metabolic panel |
9,416 |
7,689 |
$65K |
| 84484 |
|
7,702 |
5,304 |
$53K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,397 |
8,419 |
$51K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,806 |
1,624 |
$45K |
| 71046 |
Radiologic examination, chest; 2 views |
380 |
319 |
$43K |
| 36415 |
Collection of venous blood by venipuncture |
8,564 |
7,090 |
$30K |
| 87634 |
|
492 |
440 |
$28K |
| 81025 |
|
4,640 |
3,887 |
$27K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
611 |
518 |
$19K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,089 |
907 |
$18K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
751 |
702 |
$18K |
| 83690 |
|
5,103 |
4,126 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,526 |
1,039 |
$16K |
| 81001 |
|
7,249 |
5,912 |
$14K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
409 |
318 |
$9K |
| 83735 |
|
1,975 |
1,606 |
$9K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
18 |
13 |
$8K |
| 87631 |
|
41 |
37 |
$5K |
| 83880 |
|
226 |
198 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
316 |
231 |
$4K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
165 |
52 |
$4K |
| 87430 |
|
473 |
420 |
$4K |
| 80076 |
|
843 |
704 |
$3K |
| 81003 |
|
2,017 |
1,684 |
$3K |
| 83605 |
|
697 |
514 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
12 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
101 |
86 |
$2K |
| 87400 |
|
173 |
159 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
16 |
13 |
$2K |
| 85379 |
|
148 |
116 |
$987.61 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
140 |
116 |
$709.73 |
| 87081 |
|
186 |
169 |
$682.23 |
| 82077 |
|
59 |
54 |
$630.49 |
| 80143 |
|
28 |
27 |
$402.12 |
| 84145 |
|
20 |
14 |
$378.37 |
| 87807 |
|
32 |
27 |
$297.20 |
| 81000 |
|
50 |
45 |
$213.28 |
| 80179 |
|
16 |
15 |
$179.56 |
| 84100 |
|
54 |
50 |
$161.23 |
| 85610 |
|
41 |
33 |
$110.79 |
| 85730 |
|
23 |
20 |
$89.90 |
| 82803 |
|
23 |
15 |
$22.84 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,073 |
3,977 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
355 |
254 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
49 |
41 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
129 |
78 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
62 |
40 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,945 |
2,381 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
26 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
59 |
39 |
$0.00 |